Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
APRE compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
APRE
Aprea Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
APRE
Aprea Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
APRE
with
LLY
No shared trading history for APRE and LLY.
Shared co-movers: not yet measured (APRE).
APRE, solid
LLY, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
APRE
Aprea Therapeutics, Inc.
Change
0.48
▼
−4.79%
Mkt cap
$7.2M
Revenue
$3,337
Q4 FY25
Revenue
$285,759
FY25
LLY
ELI Lilly & Co
Change
1,407.15
▼
−0.76%
Regular session
Nov 5 '26
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Regular session
Nov 5 '26
APRE
Aprea Therapeutics, Inc.
vs
LLY
ELI Lilly & Co
0.48
▼
−4.79%
Price
1,407.15
▼
−0.76%
$7.2M
Mkt cap
$1.3T
Q4 FY25
$3,337
Revenue
$24.4B
Q3 FY26
FY25
$285,759
Revenue
$65.2B
FY25
Change
Change
APRE
0.48
▼
−4.79%
vs
LLY
1,407.15
▼
−0.76%
Regular session
Nov 5 '26